About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT03495791

Educational Intervention to Improve Patient-Physician Awareness of Cardiovascular Risk in Rheumatoid Arthritis.

This study will provide an educational intervention through means of a video to educate subjects on the risk of cardiovascular health on Rheumatoid arthritis.

Lead sponsor: Rush University Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Rush University Medical Center

Collaborators

Pfizer

Subjects will be randomized into an interventional group and non-interventional group. Both groups will perform several surveys before an educational intervention may be given. Both Groups will come back 3 months post visit to complete additional surveys.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Clinical Diagnoses of Rheumatoid Arthritis of at least 3 months by a Rheumatologist

Exclusion Criteria

•Inability to communicate in English.

Related studies

An Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis

NCT07627542 · Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), and more

RECRUITINGPhase 2

Desloratadine as Adjunct Therapy for Rheumatoid Arthritis

NCT07632872 · Rheumatoid Arthritis (RA), Rheumatoid Arthritis

RECRUITINGPhase 1/2

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

NCT06733935 · Systemic Sclerosis, Idiopathic Inflammatory Myopathies, and more

RECRUITINGPhase 1

Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease

NCT07455578 · Autoimmune Diseases, Rheumatoid Arthritis (RA), and more

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

NCT07171983 · Rheumatoid Arthritis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 3, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment300

Start dateOct 2016

Last updatedMay 3, 2022

Condition

Rheumatoid Arthritis Arthritis, Rheumatoid

Locations shown

Rush University Medical Center

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 3, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions